» Articles » PMID: 32446285

A Guide to COVID-19: a Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2

Overview
Journal FEBS J
Specialty Biochemistry
Date 2020 May 24
PMID 32446285
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence of the SARS-CoV-2 strain of the human coronavirus has thrown the world into the midst of a new pandemic. In the human body, the virus causes COVID-19, a disease characterized by shortness of breath, fever, and pneumonia, which can be fatal in vulnerable individuals. SARS-CoV-2 has characteristics of past human coronaviruses, with close genomic similarities to SARS-CoV, the virus that causes the disease SARS. Like these related coronaviruses, SARS-CoV-2 is transmitted through the inhalation of droplets and interaction with contaminated surfaces. Across the world, laboratories are developing candidate vaccines for the virus - with vaccine trials underway in the United States and the United Kingdom - and considering various drugs for possible treatments and prophylaxis. Here, we provide an overview of SARS-CoV-2 by analyzing its virology, epidemiology, and modes of transmission while examining the current progress of testing procedures and possible treatments through drugs and vaccines.

Citing Articles

Impact of COVID-19 on orthopedic trauma patients from 2021 to 2022 when restrictions were lifted, compared with the pre-pandemic period.

Morisaki S, Yoshii K, Tsuchida S, Oda R, Takahashi K J Orthop Surg Res. 2025; 20(1):158.

PMID: 39940006 PMC: 11823037. DOI: 10.1186/s13018-025-05554-0.


Impact of Vaccination Status on COVID-19 Severity and Pulmonary Involvement.

Laitin S, Baditoiu L, Laza R, Besliu R, Stoicescu E, Gug M Medicina (Kaunas). 2025; 60(12.

PMID: 39768801 PMC: 11678390. DOI: 10.3390/medicina60121919.


Unilateral Anterior Scleritis Following the Booster Shot of Inactivated COVID-19 (Sinopharm) Vaccine in a 52-Year-Old Woman: A Case Report.

Jazi K, Rahimi M, Hasani F, Shirmohammadi M, Masoumi M Case Rep Rheumatol. 2025; 2024:6614757.

PMID: 39759247 PMC: 11699981. DOI: 10.1155/crrh/6614757.


Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study.

Vazquez-Alejo E, De La Sierra Espinar-Buitrago M, Magro-Lopez E, Tarancon-Diez L, Diez C, Bernardino J Med Microbiol Immunol. 2024; 214(1):4.

PMID: 39724280 PMC: 11671559. DOI: 10.1007/s00430-024-00813-z.


The value of using COVID-19 antibody tests as a potential approach to prioritize vaccination delivery.

Alrabadi N, Obeidat H, Haddad R, Alyassin N, Alzoubi K, Obeidat O PLoS One. 2024; 19(10):e0311881.

PMID: 39413075 PMC: 11482680. DOI: 10.1371/journal.pone.0311881.


References
1.
Chen J, Ma E, Harrington L, Da Costa M, Tian X, Palefsky J . CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018; 360(6387):436-439. PMC: 6628903. DOI: 10.1126/science.aar6245. View

2.
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team . The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Wkly. 2021; 2(8):113-122. PMC: 8392929. View

3.
Furuta Y, Komeno T, Nakamura T . Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci. 2017; 93(7):449-463. PMC: 5713175. DOI: 10.2183/pjab.93.027. View

4.
Amanat F, Krammer F . SARS-CoV-2 Vaccines: Status Report. Immunity. 2020; 52(4):583-589. PMC: 7136867. DOI: 10.1016/j.immuni.2020.03.007. View

5.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View